Monitoring HPV infection

Patient Care

Volumn 34, Issue 5, 2000, Pages 143-167

  Schaffner, William ^a,b   Sedlacek, Thomas A ^c,d,e   Steller, Michael A ^f,g  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Patient Care Subspecialist Advisory Board ^*  (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^e GRADUATE HOSPITAL   (United States)

^f BROWN UNIVERSITY   (United States)

^g WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24644453954     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Beutner KR, Reitano MV, Richwald GA, et al. External genital warts: report of the American Medical Association Consensus Conference. Clin Infect Dis. 1998;27:796-806.
2. Edwards L, Ferenczy A, Eron L, et al. Self-administered topical imiquimod cream for external anogenital warts. Arch Dermatol. 1998;134:25-30.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
4. Wallin KL, Wikllund F, Angstrom T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl Med. 1999;341:1633-1638.
5. Burk RD. Pernicious papillomavirus infection. N Engl J Med. 1999;341:1687-1688.
6. Rice PS, Cason J, Best JM, et al. High risk genital papillomavirus infections are spread vertically. Rev Med Virol. 1999;9:15-21.
7. Sedlacek TV. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol. 1999;42:206-220.
8. Ho GYF, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423-428.
9. Griffiths TRL, Mellon JK. Human papillomavirus and urological tumours: I. Basic science and role in penile cancer. BJU Int. 1999;84:579-586.
10. Gillison ML, Koch WM, Shah KV. Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease? Cun Opin Oncol. 1999;11:191-199.
11. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610.
12. Wright TC Jr, Denny L, Kuhn L, et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000;283:81-86.
13. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica. JAMA. 2000;283:87-93.
14. Cox JT. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings. JAMA. 1999;281:1645-1647.
15. Langley PC, Tyring SK, Smith MH. The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts. Am J Managed Care. 1999;5:69-77.
16. Tyring SK, Arany I, Stanley MA, et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis. 1998;178:551-555.
17. Murakami M, Gurski KJ, Steller MA. Human papillomavirus vaccines for cervical cancer. J Immunother. 1999;22:212-218.